Decline in Youth E-Cigarette Use in US

Industry Insight by 2FIRSTS.ai
Nov.20.2023
Decline in Youth E-Cigarette Use in US
Teen e-cigarette use in the US hits lowest point in a decade, with 10% using fruit-flavored e-cigarettes in 2023, according to CDC.

According to a press release from Reuters on November 16th, a recent study report by the Centers for Disease Control and Prevention (CDC) in the United States revealed that the prevalence of e-cigarette use among American teenagers has reached its lowest point in nearly a decade. The proportion of teenagers using flavored e-cigarettes is projected to decrease from 14% in 2022 to 10% in 2023.

 

The significant drop in sales is related to the increase in e-cigarette prices and the policy of raising the minimum purchasing age to 21.

 

According to a study conducted in Brazil, approximately 2.2 million adults in the country regularly use e-cigarettes, and the number is on the rise.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI AI White Paper Warns of “Cognitive Atrophy” and Attention Erosion, Calls for Focus on Human Cognition’s Evolution
PMI AI White Paper Warns of “Cognitive Atrophy” and Attention Erosion, Calls for Focus on Human Cognition’s Evolution
Philip Morris International (PMI) has released a white paper calling for cross-sector dialogue on how AI may affect human cognitive abilities. The paper flags risks including “cognitive atrophy” and attention erosion, and warns of a widening cognitive divide and rising pressures on information verification and trust.
Jan.21 by 2FIRSTS.ai
GEEK BAR to Return to the European Market: Launches the SPARK Pod System
GEEK BAR to Return to the European Market: Launches the SPARK Pod System
GEEK BAR announced its return to the European market and the release of its pod-based product, SPARK, which will begin rolling out across select European countries starting in March. SPARK features a battery-status display interface and a fast-charging battery. It offers a 1.1Ω prefilled pod (up to approximately 1,000 puffs) and a 0.8Ω refillable pod, along with multiple new flavors tailored for Europe.
Mar.04 by 2FIRSTS.ai
Haypp confirms exit from UK vape category as it shifts focus to oral nicotine
Haypp confirms exit from UK vape category as it shifts focus to oral nicotine
Haypp, an online retailer of alternative nicotine products, has confirmed it is exiting the UK vape category as it shifts focus to the oral nicotine market. The company said analysis of its sales data showed increasing adoption of nicotine pouches across its six international markets: the UK, the USA, Germany, Norway, Switzerland and Sweden.
Mar.04 by 2FIRSTS.ai
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
The Irish government has approved the publication of the Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026. The bill would ban the sale of nicotine consumption products such as nicotine pouches to those under 18 and further regulate nicotine vaping products.
Mar.05 by 2FIRSTS.ai
Product | “Mini Water-Bottle” Design, Rated at 60,000 Puffs: Al Fakher Launches New Disposable in the U.S. and UAE
Product | “Mini Water-Bottle” Design, Rated at 60,000 Puffs: Al Fakher Launches New Disposable in the U.S. and UAE
E-cigarette brand Al Fakher has recently listed its disposable hookah-style device, the Al Fakher Crown Bar 60K E-Hose X, across multiple online retail channels in the United States and the United Arab Emirates. The product features a mini water-bottle-like design, is rated for up to 60,000 puffs, comes with a 50ml e-liquid reservoir and a 1,000mAh rechargeable battery, and supports dual DTL/MTL vaping modes.
Jan.28 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11